AsymmetRx Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

AsymmetRx General Information

Description

Developer of drug and medical devices based in Acton, Massachusetts. The company has developed the p63 gene which is involved in the diagnosis of prostate cancer and many other cancers, helping pathologists with accurate diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Other Devices and Supplies
Corporate Office
  • 100 Powder Mill Road
  • Suite 177
  • Acton, MA 01720
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AsymmetRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view AsymmetRx’s complete valuation and funding history, request access »

AsymmetRx Executive Team (4)

Name Title Board Seat Contact Info
Peter McKeon Managing Director & President
Frank McKeon Ph.D Executive
Matthew Vincent Ph.D Executive
You’re viewing 3 of 4 executive team members. Get the full list »

AsymmetRx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view AsymmetRx’s complete investors history, request access »

AsymmetRx FAQs

  • When was AsymmetRx founded?

    AsymmetRx was founded in 2001.

  • Who is the founder of AsymmetRx?

    Jun Liu Ph.D is the founder of AsymmetRx.

  • Where is AsymmetRx headquartered?

    AsymmetRx is headquartered in Acton, MA.

  • What industry is AsymmetRx in?

    AsymmetRx’s primary industry is Drug Discovery.

  • Is AsymmetRx a private or public company?

    AsymmetRx is a Private company.

  • What is AsymmetRx’s current revenue?

    The current revenue for AsymmetRx is 00000.

  • Who are AsymmetRx’s investors?

    Johns Hopkins Technology Ventures has invested in AsymmetRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »